DK0681479T3 - Immunterapeutisk præparat - Google Patents

Immunterapeutisk præparat

Info

Publication number
DK0681479T3
DK0681479T3 DK94905639T DK94905639T DK0681479T3 DK 0681479 T3 DK0681479 T3 DK 0681479T3 DK 94905639 T DK94905639 T DK 94905639T DK 94905639 T DK94905639 T DK 94905639T DK 0681479 T3 DK0681479 T3 DK 0681479T3
Authority
DK
Denmark
Prior art keywords
present
preparation
immunotherapeutic preparation
immunotherapeutic
abort
Prior art date
Application number
DK94905639T
Other languages
English (en)
Inventor
Stanley J Alkemade
Graeme Mcrae
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Application granted granted Critical
Publication of DK0681479T3 publication Critical patent/DK0681479T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK94905639T 1993-01-29 1994-01-28 Immunterapeutisk præparat DK0681479T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29
PCT/CA1994/000054 WO1994016727A1 (en) 1993-01-29 1994-01-28 Immunotherapeutic composition

Publications (1)

Publication Number Publication Date
DK0681479T3 true DK0681479T3 (da) 1999-11-08

Family

ID=21751403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94905639T DK0681479T3 (da) 1993-01-29 1994-01-28 Immunterapeutisk præparat

Country Status (11)

Country Link
US (1) US5759554A (da)
EP (1) EP0681479B1 (da)
JP (1) JPH08508976A (da)
CN (1) CN1102855C (da)
AT (1) ATE179333T1 (da)
AU (1) AU691797B2 (da)
BR (1) BR9406496A (da)
DE (1) DE69418183T2 (da)
DK (1) DK0681479T3 (da)
NZ (1) NZ261094A (da)
WO (1) WO1994016727A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
AU727781B2 (en) * 1997-04-02 2000-12-21 Bioniche Life Sciences Inc. Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease
KR100533576B1 (ko) 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법
WO2000033879A1 (en) * 1998-12-04 2000-06-15 Bioniche Life Sciences Inc. Method for the treatment of inflammation
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
AU779083B2 (en) * 1999-07-23 2005-01-06 Bioniche Life Sciences Inc. Method for enhancing production performance in an animal
EP1867718B1 (en) * 1999-12-13 2010-01-20 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
CA2395493C (en) 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
WO2001074388A1 (en) * 2000-03-31 2001-10-11 Idec Pharmaceuticals Corporation Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
JP5578390B2 (ja) * 2007-03-05 2014-08-27 株式会社 Ｍｂｒ 細菌細胞壁骨格成分の製造方法
CN105943559A (zh) 2010-10-13 2016-09-21 特莱斯塔治疗知识产权公司 细菌核糖核酸细胞壁组合物及其制备和使用方法
TR201101874A2 (tr) 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
JP2017511796A (ja) * 2014-02-18 2017-04-27 アドバクシス， インコーポレイテッド 多標的免疫療法を目的とするバイオマーカー
CN109414463A (zh) * 2016-02-25 2019-03-01 托马斯·朱利叶斯·波洛迪 治疗慢性传染性疾病的组合物和方法
CN113244384A (zh) * 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202000002641A1 (it) * 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202000002866A1 (it) * 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
IT202100013292A1 (it) * 2021-05-21 2022-11-21 Aileens Pharma S R L Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2160326B1 (da) * 1971-11-19 1975-02-07 Anvar
NL7308450A (da) * 1972-06-20 1973-12-27
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
CA1020460A (en) * 1973-02-23 1977-11-08 Wellcome Foundation Limited (The) Isolation of immunostimulating glycopeptide from bacteria
FR2269961B1 (da) * 1974-05-06 1978-03-24 Anvar
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
FR2551758B1 (fr) * 1983-08-16 1986-01-31 Anvar Derives de muramyl-peptides et de steroides ayant des proprietes d'activation des macrophages
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene

Also Published As

Publication number Publication date
ATE179333T1 (de) 1999-05-15
NZ261094A (en) 1998-04-27
DE69418183T2 (de) 1999-12-16
US5759554A (en) 1998-06-02
EP0681479B1 (en) 1999-04-28
BR9406496A (pt) 1996-01-02
EP0681479A1 (en) 1995-11-15
AU5968094A (en) 1994-08-15
CN1118574A (zh) 1996-03-13
AU691797B2 (en) 1998-05-28
DE69418183D1 (de) 1999-06-02
JPH08508976A (ja) 1996-09-24
WO1994016727A1 (en) 1994-08-04
CN1102855C (zh) 2003-03-12

Similar Documents

Publication Publication Date Title
ATE179333T1 (de) Immunotherapeutische zubereitung
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
ES2190784T3 (es) Supresion de enfermedades autoinmunes por antigenos espectadores.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
NO982062D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
KR890700353A (ko) 면역독소의 면역억제 기저 사람치료법
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
SE9601395D0 (sv) New therapeutic treatment 1
PT600396E (pt) Vacinas contra protozoarios intestinais
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
CA2154689A1 (en) Improved immunotherapeutic composition
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
DE69427533D1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
IT7828549A0 (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento.
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
RU95111615A (ru) Способ лечения органа или системы с низким уровнем ответной реакции на раздражители при умеренном или высоком уровне врожденной реакции организма в целом
BG51699A1 (en) Stimulating fertility agent
ES489956A0 (es) Sistema para la aplicacion de tratamientos bronceadores y terapeuticos integrales del cuerpo humano
UA30460A (uk) Спосіб лікування системного аутоімунного захворювання
BR9105164A (pt) Composto de peptideo,processo para produzir o mesmo,cepa,agente anti-helm intico,aditivo para racao,processo para tratar ou evitar doenca parasitica e processo para melhorar a eficiencia da racao de um animal